There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

During a live event, Martin Voss, MD, reviewed the trials of lenvatinib plus pembrolizumab, cabozantinib plus nivolumab, and ...

Structural biomarkers identifiable on OCT-A can provide details regarding the development and progression of structural changes in MacTel 2.

A nephrologist argues that advancing kidney care in the US requires tailored guidelines addressing ethnic diversity & ...

This occurs even as a significant number of offered kidneys, currently exceeding 25%, are declined for transplantation by all ...

Doctor says this common painkiller habit is ruining kidney health across India. Here are 9 kidney myths to stop believing as they can be dangerous.

Why Don't Patients Take Their Phosphate Binders? Online survey findings showed significant challenges with compliance to ...